Physician profile
Camilo E Guzman
NPI 1215180294
$5,869.08
in general payments reported to CMS, 2019-2025
12 companies · $498 in 2025
The $498 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,563 · 2020: $346 · 2021: $480 · 2022: $209 · 2023: $1,010 · 2024: $1,763 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763 · Travel and Lodging: $1,194 · Education: $230 · Long Term Medical Supply Or Device Loan: $84.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.12 |
| Travel and Lodging | $1,193.58 |
| Education | $230.00 |
| Long Term Medical Supply Or Device Loan | $84.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,358.24 | 2019-2025 | Mako, Gamma, Pangea |
| Arthrex, INC. | $1,250.44 | 2019-2024 | Arthrex |
| Depuy Synthes Sales INC. | $751.77 | 2019-2023 | Attune |
| Microport Orthopedics INC | $455.36 | 2021-2023 | Mpo Hip System |
| Orthalign INC | $343.00 | 2023-2024 | Orthalign Plus |
| Medical Device Business Services, INC. | $199.55 | 2020-2023 | |
| Boston Scientific Corporation | $125.91 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $120.10 | 2025 | |
| Heron Therapeutics, INC. | $93.17 | 2022-2025 | Aponvie |
| Baxter Healthcare | $84.71 | 2023 | |
| Next Science LLC | $70.55 | 2021 | |
| Bioventus LLC | $16.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camilo Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.